Latest Reports

Market Scope uses a multi-source methodology when preparing our annual and quarterly reports. We incorporate surgeon surveys, our extensive database of physicians and surgery centers, disease models, clinical studies, financial reports, and more. Our wide-ranging knowledge of products and technology and our comprehensive network of industry contacts also contribute to our coverage on the ophthalmic industry.

2021 Fundus Imaging Market Report: Global Analysis for 2020 to 2026, May, 2022

The “2021 Fundus Imaging Market Report” is a specialized supplement, expanding on the fundus imaging section of Market Scope’s comprehensive, global “2021 Ophthalmic Diagnostic Equipment Market Report.”

The report provides background information about fundus imaging devices and divides estimates into four categories: fundus screeners, diagnostic fundus imaging, advanced fundus imaging, and combination systems. Estimates include unit sales, installed equipment base, average prices, and information about the manufacturers that participate in the market.

2022 United States Glaucoma Atlas Featuring the Market Scope Exclusive MedOp Index™ Analysis, May, 2022

The “2022 United States Glaucoma Atlas” provides a geographic analysis of the glaucoma population and treatment opportunity in 85 US metropolitan areas. Market Scope’s proprietary MedOp Index Analysis™ analyzes market potential and provides a benchmark against other atlas metros. The atlas offers strategic insights into the top potential markets in the US, which companies often use throughout the development and commercialization processes to identify ideal clinical trial locations, develop launch strategies, define sales territories, allocate resources, and optimize sales and marketing initiatives.

2022 China Ophthalmic Market Report: Regional Analysis for 2021 to 2027, May, 2022

The “2022 China Ophthalmic Market Report” is the leading industry source for accurate and relevant information on all aspects of China’s ophthalmic market. This report provides a comprehensive overview of the Chinese population and economic conditions. It also covers disease prevalence and therapeutic approaches, including commercialized and pipeline products. The report analyzes unit demand and revenue, and it forecasts future performance over the next five years. It also includes market share data and discusses key strategic issues. Additionally, 31 market competitors are profiled, with discussion of their products, strategic market position, background, and outlook.

2022 Annual Sponsored US Cataract Surgeon Survey Report, May, 2022

Market Scope surveyed US ophthalmic surgeons during March and April 2022 to measure perceptions of practice patterns, product market share, and plans for the coming year. We received 119 responses from doctors performing cataract procedures, representing over one thousand total doctors in single doctor and group practices.

We have conducted annual surveys of US cataract surgeons on important issues regarding practice characteristics, product preferences, surgical techniques, and practice marketing since 2001. This survey highlights practice patterns regarding presbyopic-correcting IOLs (PC-IOLs), toric IOLs, extended depth of focus (EDOF) IOLs, correction of astigmatism, femtosecond laser-assisted cataract surgery (FLACS), sugical location, interest in upcoming technology, equipment use, treatment and management of glaucoma and micro-invasive glaucoma survery (MIGS) devices and much more. It measures market share by manufacturer, product, and market segment. Leading ophthalmic firms and organizations sponsor the survey in order to better understand industry dynamics and gain important insights into surgeons’ experiences and preferences, as well as emerging trends. 

2022 India Ophthalmic Market Report: Regional Analysis for 2020 to 2027, April, 2022

The “2022 India Ophthalmic Market Report” analyzes the current landscape of the Indian ophthalmic market, discussing important trends and key factors for future success, and includes forecasts of disease prevalence, numbers of treatments, and technologies used in treatments. The report analyzes the Indian markets for diagnostic equipment, lasers, cataract, refractive, cornea, glaucoma, retina, dry eye, surgical instruments, and single-use surgical devices. Thirty market competitors are profiled, with discussion of their products, strategic market positions, background, and outlook.

2022 Glaucoma Disease Model, March, 2022

Market Scope’s 2021 Glaucoma Disease Model offers extensive country-level prevalence data and five-year forecasts for glaucoma by type and by age group for all countries with a population over a million.

This proprietary model takes into consideration the latest clinical research and demographic projections on a global scale and can be customized by geography and disease category to meet clients’ diverse needs. Disease models can be used to evaluate target markets for clinical-stage and commercial-stage products and gain insights into the volume and demographics of diseased populations.

2022 United States Cataract Atlas Featuring the Market Scope Exclusive MedOp Index™ Analysis, March, 2022

The “2022 United States Cataract Atlas” provides a geographic analysis of the conventional and premium cataract surgery opportunity in 85 US metropolitan areas. Market Scope’s proprietary MedOp Index™ Analysis examines market potential and provides a benchmark against other metros. The atlas offers strategic insights into the top potential markets in the US, which companies often use throughout the development and commercialization processes to identify ideal clinical trial locations, develop launch strategies, define sales territories, allocate resources, and optimize sales and marketing initiatives.

2021 Optical Coherence Tomography Market Report: Global Analysis for 2020 to 2026, February, 2022

The “2021 Optical Coherence Tomography Market Report” provides a comprehensive analysis of the global market for OCT imagers and forecasts market performance over the next five years. It analyzes the market drivers for the OCT segment, including providers, related diseases, competitive forces, and market trends. Market estimates are divided into six categories: basic OCT models, advanced OCT models, combination OCT/fundus systems, combination OCT/SLO systems, intraoperative OCT, and OCTA. Estimates are included for unit sales, installed equipment base, and average prices. Additionally, 12 OCT manufacturers are profiled, with discussion of their products, strategic market position, background, and outlook.

2022 Glaucoma Pharmaceuticals Market Report: Global Analysis for 2021 to 2027, February, 2022

The “2022 Glaucoma Pharmaceuticals Market Report” analyzes the global and regional markets for glaucoma pharmaceuticals, identifying important trends and key factors for future success. The report provides forecasts through 2027 for branded prostaglandins, generic prostaglandins, beta blockers, carbonic anhydrase inhibitors, alpha agonists, fixed combo drugs, NO-donating compounds, and rho-kinase inhibitors. The report also extensively discusses pipeline products, covering over 30 drug candidates that are currently under development. Additionally, 29 glaucoma pharmaceutical companies are profiled, discussing their products, strategic market position, background, and outlook.

2022 Retinal Surgical Device Market Report: Global Analysis for 2021 to 2027, February, 2022

The “2022 Retinal Surgical Device Market Report” provides in-depth analysis of the global retinal device market, examining the market’s size and growth, as well as identifying important developments that may shape its future. The analysis focuses on the 2022 market and forecasts market growth and evolution through 2027. Additionally, 35 retina device companies are profiled, with discussion of their products, strategic market position, background, and outlook.

Want to Purchase the Full Report?

Register A Corporate Account

A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.

Select one or more
Select one or more